Mazzone E, Perera S, Neti AL, Chen DC, et al. Re: [(177)Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer (ENZA-p): An Open-label, Multicentre, Randomised, Phase 2 Trial. Eur Urol 2024 Jul 19:S0302-2838(24)02450-3. doi: 10.1016/j.eururo.2024.
PMID: 39033070